YAP1 and prostate cancer: WSS characteristic of flow within the lymphatic vasculature modified prostate cancer cell motility via regulation of a transcriptional cofactor, Yes‐associated protein (YAP), that has proto‐oncogenic properties and is a negative effector of the HIPPO tumor suppressor pathway.